Skip Navigation

European Heart Journal 2004 25(15):1274-1276; doi:10.1016/j.ehj.2004.06.007
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Khan, I. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, I. A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Pharmacological cardioversion of recent onset atrial fibrillation

Ijaz A Khan*

Division of Cardiology, University of Maryland School of Medicine, Baltimore, MD, USA

* Correspondence to: Ijaz A. Khan, Division of Cardiology, University of Maryland School of Medicine, 22 South Greene Street, S3B06, Baltimore, MD 21201, USA. Tel.: +1-410-328-2251; fax: +1-410-328-2255
E-mail address: ikhan@medicine.umaryland.edu

The first 150 words of the full text of this article appear below.

This editorial refers to "Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset"1 by J. Reisinger et al. on page 1318

Atrial fibrillation is the most common, clinically relevant arrhythmia with a prevalence of about 2% in the general population. The symptoms in atrial fibrillation are primarily caused by fast ventricular rates, which can be controlled by using the atrio-ventricular node blocking drugs or, even more effectively, by converting atrial fibrillation to sinus rhythm. Although the traditional treatment options available to treat atrial fibrillation are rhythm control versus ventricular rate control, the best method to control ventricular rate, however, is by conversion to sinus rhythm. Even though the reported rate of spontaneous conversion is up to 50%, in the first 24 h after the onset of atrial fibrillation, the earlier restoration of sinus rhythm by cardioversion will result in an early alleviation of the patient's symptoms, will . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset
Johann Reisinger, Edmund Gatterer, Wolfgang Lang, Thetis Vanicek, Geza Eisserer, Theresia Bachleitner, Christopher Niemeth, Friedrich Aicher, Wilhelm Grander, Georg Heinze, Peter Kühn, and Peter Siostrzonek
EHJ 2004 25: 1318-1324. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
 EuropaceHome page
F. G. Cosio, E. Aliot, G. L. Botto, H. Heidbuchel, C. J. Geller, P. Kirchhof, J.-C. De Haro, R. Frank, J. P. Villacastin, J. Vijgen, et al.
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
Europace, January 1, 2008; 10(1): 21 - 27.
[Abstract] [Full Text] [PDF]